Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetite Nanoparticles | 5 | 2017 | 309 | 1.140 |
Why?
|
| Microfluidic Analytical Techniques | 7 | 2017 | 788 | 0.930 |
Why?
|
| Magnetic Resonance Spectroscopy | 11 | 2013 | 3677 | 0.900 |
Why?
|
| Biosensing Techniques | 9 | 2017 | 642 | 0.700 |
Why?
|
| Neoplastic Cells, Circulating | 4 | 2013 | 949 | 0.630 |
Why?
|
| Nanoparticles | 14 | 2012 | 1967 | 0.630 |
Why?
|
| Silicon Dioxide | 3 | 2017 | 218 | 0.590 |
Why?
|
| Point-of-Care Systems | 4 | 2017 | 1216 | 0.560 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2017 | 314 | 0.550 |
Why?
|
| Miniaturization | 3 | 2013 | 150 | 0.530 |
Why?
|
| Plastics | 1 | 2017 | 116 | 0.530 |
Why?
|
| Filtration | 1 | 2017 | 226 | 0.520 |
Why?
|
| Influenza in Birds | 1 | 2016 | 76 | 0.500 |
Why?
|
| Biomimetics | 1 | 2017 | 167 | 0.500 |
Why?
|
| Nucleic Acids | 2 | 2017 | 190 | 0.470 |
Why?
|
| Magnetics | 8 | 2011 | 586 | 0.430 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 426 | 0.430 |
Why?
|
| Microfluidics | 2 | 2009 | 651 | 0.410 |
Why?
|
| Influenza A virus | 1 | 2016 | 453 | 0.400 |
Why?
|
| Transport Vesicles | 1 | 2012 | 79 | 0.400 |
Why?
|
| Nanotechnology | 6 | 2017 | 703 | 0.360 |
Why?
|
| Immunomagnetic Separation | 1 | 2010 | 78 | 0.350 |
Why?
|
| Models, Chemical | 1 | 2012 | 608 | 0.340 |
Why?
|
| Cell Separation | 2 | 2012 | 1718 | 0.330 |
Why?
|
| Polymers | 1 | 2017 | 1623 | 0.330 |
Why?
|
| Biological Assay | 1 | 2012 | 627 | 0.320 |
Why?
|
| Viral Proteins | 1 | 2016 | 1798 | 0.310 |
Why?
|
| Indoles | 1 | 2017 | 1832 | 0.310 |
Why?
|
| Mycobacterium bovis | 1 | 2009 | 148 | 0.300 |
Why?
|
| Biotechnology | 1 | 2008 | 284 | 0.260 |
Why?
|
| Cyclooctanes | 4 | 2013 | 37 | 0.250 |
Why?
|
| Equipment Design | 5 | 2017 | 3488 | 0.240 |
Why?
|
| Ferric Compounds | 4 | 2011 | 368 | 0.240 |
Why?
|
| Systems Integration | 1 | 2007 | 425 | 0.240 |
Why?
|
| Microspheres | 3 | 2017 | 773 | 0.230 |
Why?
|
| Cell Line, Tumor | 14 | 2017 | 17063 | 0.230 |
Why?
|
| Flow Cytometry | 2 | 2012 | 5879 | 0.230 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 1130 | 0.220 |
Why?
|
| Antibodies | 4 | 2013 | 2415 | 0.220 |
Why?
|
| Fluorescent Dyes | 4 | 2012 | 1929 | 0.170 |
Why?
|
| Staphylococcus aureus | 3 | 2012 | 1424 | 0.160 |
Why?
|
| Surface Properties | 3 | 2017 | 1153 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2012 | 3459 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2009 | 684 | 0.140 |
Why?
|
| Birds | 1 | 2016 | 165 | 0.120 |
Why?
|
| Neoplasms | 5 | 2013 | 22349 | 0.120 |
Why?
|
| Metals | 1 | 2017 | 710 | 0.110 |
Why?
|
| Exosomes | 1 | 2017 | 421 | 0.100 |
Why?
|
| Cells | 2 | 2011 | 162 | 0.100 |
Why?
|
| Gentian Violet | 1 | 2012 | 25 | 0.100 |
Why?
|
| Leukocytes | 2 | 2010 | 2027 | 0.100 |
Why?
|
| Cyclodextrins | 1 | 2011 | 62 | 0.090 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2012 | 135 | 0.090 |
Why?
|
| Ferrous Compounds | 1 | 2011 | 39 | 0.090 |
Why?
|
| Materials Testing | 2 | 2012 | 868 | 0.090 |
Why?
|
| Manganese Compounds | 1 | 2010 | 25 | 0.090 |
Why?
|
| Adamantane | 1 | 2011 | 148 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 180 | 0.090 |
Why?
|
| Polyvinyl Alcohol | 1 | 2010 | 74 | 0.090 |
Why?
|
| Staining and Labeling | 2 | 2011 | 1071 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2011 | 428 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 832 | 0.080 |
Why?
|
| Phthalazines | 1 | 2011 | 397 | 0.080 |
Why?
|
| Microchip Analytical Procedures | 1 | 2008 | 28 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 2011 | 561 | 0.080 |
Why?
|
| Proteins | 5 | 2017 | 5996 | 0.070 |
Why?
|
| Temperature | 2 | 2011 | 2226 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 36542 | 0.070 |
Why?
|
| Crystallization | 1 | 2008 | 519 | 0.070 |
Why?
|
| Quantum Dots | 1 | 2008 | 169 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 403 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 14644 | 0.060 |
Why?
|
| Cytodiagnosis | 1 | 2009 | 450 | 0.060 |
Why?
|
| Cell Count | 1 | 2009 | 1823 | 0.060 |
Why?
|
| Cell Line | 2 | 2017 | 15540 | 0.060 |
Why?
|
| Catalysis | 1 | 2007 | 770 | 0.060 |
Why?
|
| Humans | 24 | 2017 | 765823 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 3210 | 0.060 |
Why?
|
| Benchmarking | 1 | 2011 | 1054 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 1230 | 0.060 |
Why?
|
| Animals | 9 | 2016 | 168730 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2009 | 3612 | 0.050 |
Why?
|
| Nanostructures | 1 | 2008 | 549 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1393 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4883 | 0.050 |
Why?
|
| Iron | 1 | 2011 | 1814 | 0.050 |
Why?
|
| Mice | 6 | 2012 | 81788 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5018 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3592 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3716 | 0.050 |
Why?
|
| Piperazines | 1 | 2011 | 2546 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 20131 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2822 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2012 | 4211 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3794 | 0.040 |
Why?
|
| Monocytes | 1 | 2009 | 2592 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 40109 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6252 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2009 | 2592 | 0.040 |
Why?
|
| Fluorescence | 2 | 2010 | 753 | 0.030 |
Why?
|
| Particle Size | 2 | 2011 | 1632 | 0.030 |
Why?
|
| RNA | 2 | 2017 | 2716 | 0.030 |
Why?
|
| Macrophages | 1 | 2008 | 5771 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3421 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2012 | 84 | 0.030 |
Why?
|
| Photochemistry | 1 | 2012 | 238 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2012 | 613 | 0.020 |
Why?
|
| Cell Survival | 2 | 2011 | 5747 | 0.020 |
Why?
|
| Daptomycin | 1 | 2011 | 71 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2011 | 103 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2012 | 1081 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 22323 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 198 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 541 | 0.020 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2010 | 68 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2011 | 1306 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 655 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 697 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 651 | 0.020 |
Why?
|
| Vancomycin | 1 | 2011 | 504 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 499 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 1886 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 1075 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 531 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 541 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1965 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2477 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2008 | 1430 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2011 | 822 | 0.010 |
Why?
|
| Female | 3 | 2012 | 396050 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4471 | 0.010 |
Why?
|
| DNA | 1 | 2011 | 7197 | 0.010 |
Why?
|
| Male | 2 | 2012 | 363740 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9241 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7476 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9441 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16706 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 59506 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 171178 | 0.000 |
Why?
|
| Middle Aged | 1 | 2012 | 223016 | 0.000 |
Why?
|
| Adult | 1 | 2012 | 223055 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_